STAT3 Silencing in Dendritic Cells by siRNA Polyplexes Encapsulated in PLGA Nanoparticles for the Modulation of Anticancer Immune Response
- 14 September 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 7 (5), 1643-1654
- https://doi.org/10.1021/mp100067u
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Taking dendritic cells into medicineNature, 2007
- Dendritic cells: versatile controllers of the immune systemNature Medicine, 2007
- CELL BIOLOGY OF ANTIGEN PROCESSING IN VITRO AND IN VIVOAnnual Review of Immunology, 2005
- Mechanisms and functional significance of tumour-induced dendritic-cell defectsNature Reviews Immunology, 2004
- Tumor–Host Immune Interactions and Dendritic Cell DysfunctionAdvances in Cancer Research, 2004
- Mouse and human dendritic cell subtypesNature Reviews Immunology, 2002
- STAT proteins: novel molecular targets for cancer drug discoveryOncogene, 2000
- Dendritic cells: Immunological sentinels with a central role in health and diseaseImmunology & Cell Biology, 2000
- T-cell priming by type-1and type-2 polarized dendritic cells: the concept of a third signalImmunology Today, 1999
- Dendritic cells and the control of immunityNature, 1998